Filing Details
- Accession Number:
- 0001596783-20-000181
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2020-10-05 19:55:21
- Reporting Period:
- 2020-10-02
- Accepted Time:
- 2020-10-05 19:55:21
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1596783 | Catalent Inc. | CTLT | Pharmaceutical Preparations (2834) | 208737688 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1705828 | Scott Gunther | C/O Catalent, Inc. 14 Schoolhouse Road Somerset NJ 08873 | Svp, Quality & Reg. Affairs | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2020-10-02 | 7,347 | $36.02 | 26,249 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2020-10-02 | 5,200 | $84.94 | 21,049 | No | 4 | F | Direct | |
| Common Stock | Disposition | 2020-10-02 | 2,665 | $85.80 | 18,384 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2020-10-02 | 1,645 | $84.94 | 16,739 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2020-10-02 | 49 | $86.22 | 16,690 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | F | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Options to purchase Common Stock | Disposition | 2020-10-02 | 7,347 | $0.00 | 7,347 | $36.02 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 2,452 | 2027-07-24 | No | 4 | M | Direct |
Footnotes
- This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person in order to implement a plan of financial diversification.
- Includes restricted stock units.
- Represents shares withheld to pay the exercise price and applicable withholding taxes associated with the exercise of stock options pursuant to the Rule 10b5-1 trading plan noted in footnote 1.
- Represents shares sold pursuant to the Rule 10b5-1 trading plan noted in footnote 1.
- Volume-weighted average price. These shares were sold in multiple transactions at prices ranging from $85.48 to $86.14, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- The options vest and become exercisable in four equal annual installments beginning on July 24, 2018.
Billionaire Hedge Funds
